|
Rose-Leigh readies for stem cells
Independent Online Rose-Leigh’s family and doctor hope the stem cell transplant will give her a new lease on life. The little girl has a generally incurable form of lymphoma, with the longest survival rate being 16 months after detection and most patients dying from the … |
Rapid, scalable and highly automated HLA genotyping using next-generation … – 7thSpace Interactive (press release)
Rapid, scalable and highly automated HLA genotyping using next-generation …7thSpace Interactive (press release)Thus, next-generation sequencing is entering into diagnostic laboratories at the perfect time and serving as a promising tool to overcome i…
Multiple Sklerose: Daclizumab HYP halbiert Schubfrequenz – Deutsches Ärzteblatt
 Hannover Zeitung |
Multiple Sklerose: Daclizumab HYP halbiert Schubfrequenz
Deutsches Ärzteblatt Bochum – Der monoklonale Antikörper Daclizumab HYP, eine Variante des 1999 zur Prophylaxe akuter Abstoßungsreaktionen nach Nierentransplantation eingeführten Immunsuppressivums Daclizumab, hat in einer Phase-II-Studie vielversprechende … Multiple Sklerose: Daclizumab HYP halbiert die Wahrscheinlichkeit von SchübenInformationsdienst Wissenschaft (Pressemitteilung) Vielversprechender neuer Wirkstoff gegen Multiple SklerosederStandard.at |
Lancet Publishes SELECT Study of Biogen's Daclizumab HYP, Biogen Says … – Benzinga
|
Lancet Publishes SELECT Study of Biogen’s Daclizumab HYP, Biogen Says …
Benzinga Today Biogen Idec (NASDAQ: BIIB) announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as an online article in The Lancet. SELECT was a Phase 2b study designed to determine the efficacy … Market opening: Biogen Idec up after positive MS drug studyMarketWatch (blog) |
The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of … – Financial Post
The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of …Financial PostToday Biogen Idec (NASDAQ: BIIB) announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as an online article…
The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of … – MarketWatch (press release)
The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of …MarketWatch (press release)Today Biogen Idec (NASDAQ:BIIB) announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as an on…
Siberian scientists test anti-ageing pills on themselves – Russia & India Report
|
Siberian scientists test anti-ageing pills on themselves
Russia & India Report Siberian scientists have tested newly-developed drugs for the treatment of liver cirrhosis – more widely known as ‘anti-ageing pills’ – on themselves, without waiting for the results of clinical trials. The developers said they’d noticed very positive … |
National Cancer Institution: Major steps taken on breast cancer and leukemia – Ahram Online
 Ahram Online |
National Cancer Institution: Major steps taken on breast cancer and leukemia
Ahram Online Kamal then moved on to explain that before 2000 there was no medication and the only option was a risky stem cell transplant. After 2000, came two generations of “targeted medication” — the first being a ray of hope, the second the chance of a cure. |
Rahul's speech impressive, he spoke from heart: India Inc – Zee News
 Zee News |
Rahul’s speech impressive, he spoke from heart: India Inc
Zee News Sam Pitroda, adviser to Prime Minister, also said, “I liked it. I think he spoke from his heart. He talked about inclusive growth and collaboration. I have worked with him. We have a very long relationship with Rajiv Gandhi and the family, and with … |
Rahul's speech impressive, he spoke from heart, India Inc says – Times of India
Zee News |
Rahul’s speech impressive, he spoke from heart, India Inc says
Times of India NEW DELHI: India Inc was impressed by Congress leader Rahul Gandhi’s maiden interaction with corporate leaders on Thursday saying he came across as a sincere leader and this can form the basis for future engagement with the industry. “It was a very … Rahul’s speech impressive, he spoke from heart: India IncZee News Rahuls Speech Impressive, He Spoke From Heart, India Inc SaysSiliconindia.com Gandhi says growth in ‘beehive’ India must help poorDAWN.com NDTV all 174 news articles » |